At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Jim Routt
Advertisement
Vice President and Unit Head, Oncology Global Therapeutic Delivery, IQVIA
Articles by Jim Routt
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
How AI Is Changing Endpoint Selection Before a Trial Even Starts
2
How to recruit specialty volunteer populations for early-phase clinical research: 5 things to ask when choosing a CRO partner
3
Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It
4
Clinical Site Readiness for Cell and Gene Therapies: Operational and Supply Chain Challenges as they Scale and as they Expand into the Community Care Setting
5